Literature DB >> 29678261

Mirtazapine.

Abdulrahman Al-Majed1, Ahmed H Bakheit2, Raed M Alharbi1, Hatem A Abdel Aziz3.   

Abstract

Mirtazapine is one of antidepression which is used mainly in the treatment of depression, moreover, it is sometimes used in the treatment of anxiety disorders, insomnia, nausea, and vomiting, and to produce weight gain when desirable. The action of mirtazapine is an antagonist of certain adrenergic and serotonin receptors, and, furthermore, the drug is used strong as antihistamine, and it is occasionally defined as a noradrenergic and specific serotonergic antidepressant (NaSSA). The comprehensive profile of mirtazapine gives more detailed information about nomenclature, formulae, elemental analysis, and appearance. In addition, the numerous methods of drug synthesis are summarized. Also the profile covers the physicochemical properties as: the value of pKa, drug solubility, melting point, X-ray powder diffraction, and analysis methods for example: (compendial, electrochemical, spectroscopic, and method of chromatographic). Besides that, the profile covered pharmacological profile and clinical pharmacokinetics in subtitle's (absorption, distribution, metabolism, and elimination). About 100 references were given as a proof of the above-mentioned studies.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical pharmacokinetics; Method of analysis; Mirtazapine; Nomenclature; Pharmacological profile; Physical characteristics; Spectroscopy; Stability; Synthesis

Mesh:

Substances:

Year:  2018        PMID: 29678261     DOI: 10.1016/bs.podrm.2018.01.002

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  3 in total

Review 1.  Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia.

Authors:  Mehnaz Ahmed; Marlene Malik; Johannes Teselink; Krista L Lanctôt; Nathan Herrmann
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

2.  Formulation Development of Mirtazapine Liquisolid Compacts: Optimization Using Central Composite Design.

Authors:  Faiza Naureen; Yasar Shah; Sayyed Ibrahim Shah; Muhammad Abbas; Inayat Ur Rehman; Salar Muhammad; Hamdullah Hamdullah; Khang Wen Goh; Fazli Khuda; Amjad Khan; Siok Yee Chan; Mehwish Mushtaq; Long Chiau Ming
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

3.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.